Cohen Jordana B, Wong Tiffany C, Alpert Bruce S, Townsend Raymond R
Renal, Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA.
Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
J Clin Hypertens (Greenwich). 2017 Mar;19(3):296-302. doi: 10.1111/jch.12961. Epub 2017 Jan 12.
The OMRON HEM-907XL is a commercial oscillometric blood pressure (BP) monitor that was used in the Systolic Blood Pressure Intervention Trial (SPRINT), in which 28% of participants had chronic kidney disease (CKD). This study examined the accuracy of the monitor in nondialytic patients with CKD. Eighty-seven patients met inclusion criteria. The authors used a modified Association for the Advancement of Medical Instrumentation (AAMI) protocol, with one observer recording measurements from the monitor and two blinded physicians obtaining simultaneous aneroid values by auscultation. Using AAMI method 1, there was a 2.5±9.5 mm Hg difference in OMRON and aneroid systolic BP, and a -1.6±6.5 mm Hg difference in diastolic BP. Using AAMI method 2, there was a 5.1±7.4 mm Hg difference in systolic BP and a -0.2±5.4 mm Hg difference in diastolic BP. In patients with CKD, the OMRON HEM-907XL appears to be accurate for measuring diastolic BP, but did not perform as well for systolic BP.
欧姆龙HEM - 907XL是一款商用示波法血压监测仪，曾用于收缩压干预试验（SPRINT），该试验中有28%的参与者患有慢性肾脏病（CKD）。本研究检测了该监测仪在非透析CKD患者中的准确性。87名患者符合纳入标准。作者采用了改良的美国医疗仪器促进协会（AAMI）方案，由一名观察者记录监测仪测量值，两名不知情的医生通过听诊同时获取汞柱式血压计测量值。采用AAMI方法1时，欧姆龙与汞柱式血压计收缩压差值为2.5±9.5 mmHg，舒张压差值为 -1.6±6.5 mmHg。采用AAMI方法2时，收缩压差值为5.1±7.4 mmHg，舒张压差值为 -0.2±5.4 mmHg。在CKD患者中，欧姆龙HEM - 907XL测量舒张压似乎准确，但测量收缩压的表现欠佳。
